FAQs Archive - Strive CLE Counseling LLC

Q: Why Choose Strive CLE Counseling?

We offer an integrative approach that combines medical supervision under psychiatric providers with trauma-informed therapy. Our setting is designed for safety and comfort, providing on-site therapeutic support and mindfulness-based integration during your recovery.

Q: What can I expect after my appointment?

You may feel relaxed or drowsy for several hours. You must arrange for transportation home and avoid driving or operating machinery for 24 hours after treatment. Resting and hydrating are highly recommended.

Q: Who might benefit from Spravato?

Spravato is designed for adults who have not had sufficient improvement from at least two other antidepressants, or those experiencing major depressive episodes that haven't responded to oral medication alone.

Q: What is the standard treatment schedule?

The protocol begins with an induction phase of twice-weekly sessions for the first four weeks. This is followed by once-weekly sessions for several weeks, then a maintenance phase—typically once every two weeks—tailored to your individual response.

Q: Are there side effects?

Common side effects include dizziness, feeling 'spacey,' sedation, nausea, and mild increases in blood pressure. These usually occur shortly after administration and resolve before you leave the office. Clinical staff monitor your comfort and vitals throughout the session.

Q: How is it administered?

Spravato is self-administered via a nasal spray in a comfortable, private clinical space. You will take the medication yourself in three doses spaced several minutes apart, followed by a relaxation and observation period lasting at least two hours.

Q: Is Spravato covered by insurance?

Most major insurance carriers, including Medicaid and commercial plans, cover Spravato when prior authorization criteria are met. Our administrative team verifies your benefits and assists with the Spravato withME cost savings program to lower out-of-pocket costs.

Q: Can Spravato Help Me?

Spravato has been extensively studied for depression that does not respond to standard antidepressants. Clinical trials show that it can reduce relapse risk by 51% and provide symptom relief as quickly as 24 hours after the first dose for some patients.

Q: How is Spravato Different from Ketamine Infusions?

While both act on the glutamate system, ketamine infusions are administered intravenously and used 'off-label.' Spravato is FDA-approved specifically for depression and delivered as a nasal spray, providing more predictable dosing and broader insurance coverage.

Q: Is Spravato Addicting?

Spravato is designed and administered in a controlled medical environment to minimize risk. According to the FDA and clinical data, it carries a low potential for abuse because it is never dispensed for home use. Long-term safety studies found no evidence of physical dependence among patients.

Telehealth and In-Person Options Available

CLIENT PORTAL